SE0101038D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0101038D0
SE0101038D0 SE0101038A SE0101038A SE0101038D0 SE 0101038 D0 SE0101038 D0 SE 0101038D0 SE 0101038 A SE0101038 A SE 0101038A SE 0101038 A SE0101038 A SE 0101038A SE 0101038 D0 SE0101038 D0 SE 0101038D0
Authority
SE
Sweden
Prior art keywords
sup
novel compounds
therapy
general formula
pharmaceutical compositions
Prior art date
Application number
SE0101038A
Other languages
English (en)
Swedish (sv)
Inventor
Tomas Eriksson
Karolina Lawitz
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101038A priority Critical patent/SE0101038D0/xx
Publication of SE0101038D0 publication Critical patent/SE0101038D0/xx
Priority to DE60218641T priority patent/DE60218641T2/de
Priority to EP02708893A priority patent/EP1372651B1/en
Priority to AT02708893T priority patent/ATE355842T1/de
Priority to ES02708893T priority patent/ES2280511T3/es
Priority to PCT/SE2002/000541 priority patent/WO2002076457A1/en
Priority to KR10-2003-7012302A priority patent/KR20030085030A/ko
Priority to NZ528296A priority patent/NZ528296A/en
Priority to MXPA03008443A priority patent/MXPA03008443A/es
Priority to SI200230517T priority patent/SI1372651T1/sl
Priority to DK02708893T priority patent/DK1372651T3/da
Priority to CA002441933A priority patent/CA2441933A1/en
Priority to US10/472,017 priority patent/US7345063B2/en
Priority to JP2002574972A priority patent/JP2004524345A/ja
Priority to BR0208336-1A priority patent/BR0208336A/pt
Priority to CNA028070968A priority patent/CN1538844A/zh
Priority to IL15765302A priority patent/IL157653A0/xx
Priority to PT02708893T priority patent/PT1372651E/pt
Priority to ZA200306792A priority patent/ZA200306792B/en
Priority to NO20034215A priority patent/NO20034215L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0101038A 2001-03-23 2001-03-23 Novel compounds SE0101038D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE0101038A SE0101038D0 (sv) 2001-03-23 2001-03-23 Novel compounds
PT02708893T PT1372651E (pt) 2001-03-23 2002-03-19 Novas amidas, preparação e utilização terapia como moduladores da actividade do receptor ccr
MXPA03008443A MXPA03008443A (es) 2001-03-23 2002-03-19 Amidas nuevas, preparacion y uso terapeutico como moduladores de actividad del receptor ccr.
DK02708893T DK1372651T3 (da) 2001-03-23 2002-03-19 Hidtil ukendte amider, fremstilling og terapeutisk anvendelse som modulatorer af CCR-receptoraktivitet
AT02708893T ATE355842T1 (de) 2001-03-23 2002-03-19 Neue amide, herstellung und therapeutische verwendung als modulatoren der ccr-rezeptor- aktivität
ES02708893T ES2280511T3 (es) 2001-03-23 2002-03-19 Nuevas amidas, preparacion y uso terapeutico como moduladores de la actividad del receptor de ccr.
PCT/SE2002/000541 WO2002076457A1 (en) 2001-03-23 2002-03-19 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
KR10-2003-7012302A KR20030085030A (ko) 2001-03-23 2002-03-19 신규 아미드, 이의 제법 및 ｃｃｒ-수용체 활성조절자로서의 치료 용도
NZ528296A NZ528296A (en) 2001-03-23 2002-03-19 Novel amides, preparation and therapeutic use as modulators of CCR-receptor activity
DE60218641T DE60218641T2 (de) 2001-03-23 2002-03-19 Neue amide, herstellung und therapeutische verwendung als modulatoren der ccr-rezeptor-aktivität
SI200230517T SI1372651T1 (sl) 2001-03-23 2002-03-19 Novi amidi, priprava in terapevtska uporaba kot modulatorji aktivnosti CCR-receptorjev
EP02708893A EP1372651B1 (en) 2001-03-23 2002-03-19 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
CA002441933A CA2441933A1 (en) 2001-03-23 2002-03-19 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
US10/472,017 US7345063B2 (en) 2001-03-23 2002-03-19 Amides, preparation and therapeutic use as modulators of CCR-receptor activity
JP2002574972A JP2004524345A (ja) 2001-03-23 2002-03-19 Ｃｃｒ受容体活性のモジュレーターとしての新規アミド、製法、および治療的使用
BR0208336-1A BR0208336A (pt) 2001-03-23 2002-03-19 Novas amidas, preparação e uso terapêutico como moduladores de atividade de receptor-ccr
CNA028070968A CN1538844A (zh) 2001-03-23 2002-03-19 用作ccr受体活性调节剂的新型酰胺类化合物、其制备及治疗用途
IL15765302A IL157653A0 (en) 2001-03-23 2002-03-19 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
ZA200306792A ZA200306792B (en) 2001-03-23 2003-08-29 Novel amides, preparation and therapeutic use as modulators of CCR-receptor activity.
NO20034215A NO20034215L (no) 2001-03-23 2003-09-22 Nye amider, fremstilling og terapeutisk anvendelse av modulatorer av CCR-reseptoraktivitet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101038A SE0101038D0 (sv) 2001-03-23 2001-03-23 Novel compounds

Publications (1)

Publication Number Publication Date
SE0101038D0 true SE0101038D0 (sv) 2001-03-23

Family

ID=20283509

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101038A SE0101038D0 (sv) 2001-03-23 2001-03-23 Novel compounds

Country Status (20)

Country Link
US (1) US7345063B2 (enExample)
EP (1) EP1372651B1 (enExample)
JP (1) JP2004524345A (enExample)
KR (1) KR20030085030A (enExample)
CN (1) CN1538844A (enExample)
AT (1) ATE355842T1 (enExample)
BR (1) BR0208336A (enExample)
CA (1) CA2441933A1 (enExample)
DE (1) DE60218641T2 (enExample)
DK (1) DK1372651T3 (enExample)
ES (1) ES2280511T3 (enExample)
IL (1) IL157653A0 (enExample)
MX (1) MXPA03008443A (enExample)
NO (1) NO20034215L (enExample)
NZ (1) NZ528296A (enExample)
PT (1) PT1372651E (enExample)
SE (1) SE0101038D0 (enExample)
SI (1) SI1372651T1 (enExample)
WO (1) WO2002076457A1 (enExample)
ZA (1) ZA200306792B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
US7005439B2 (en) * 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
AR028948A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
EP1661889A4 (en) * 2003-09-05 2009-08-05 Ono Pharmaceutical Co ANTAGONIST OF THE CHEMOKINE RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
AU2006264043B2 (en) 2005-06-28 2012-04-26 Sanofi-Aventis Isoquinoline derivatives as inhibitors of Rho-kinase
CN101228132B (zh) 2005-07-26 2012-10-10 塞诺菲-安万特股份有限公司 作为Rho-激酶抑制剂的环己基胺异喹啉酮衍生物
CN101228149B (zh) 2005-07-26 2013-01-02 塞诺菲-安万特股份有限公司 作为Rho-激酶抑制剂的哌啶基取代的异喹啉酮衍生物
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
AU2007338412B2 (en) 2006-12-27 2013-03-14 Sanofi-Aventis Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
MX2009006517A (es) 2006-12-27 2009-06-26 Sanofi Aventis Nuevos derivados de isoquinolina e isoquinolinona sustituidos.
NZ577981A (en) 2006-12-27 2011-12-22 Sanofi Aventis Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
RU2457203C2 (ru) 2006-12-27 2012-07-27 Санофи-Авентис Замещенные циклоалкиламином производные изохинолона
BRPI0720909A2 (pt) 2006-12-27 2016-11-01 Sanofi Aventis derivados de isoquinolina e isoquinolinona substituídos
EP2125746B1 (en) 2006-12-27 2012-04-18 Sanofi Cycloalkylamine substituted isoquinoline derivatives
MY157330A (en) 2008-06-24 2016-05-31 Sanofi Aventis Substituted isoquinolinones as rho kinase inhibitors
AU2009262509B2 (en) 2008-06-24 2014-01-30 Sanofi Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as Rho kinase inhibitors
KR101607090B1 (ko) 2008-06-24 2016-03-29 사노피 6-치환된 이소퀴놀린 및 이소퀴놀리논

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1220440B (de) * 1962-02-14 1966-07-07 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von Derivaten des 1-(o-Bromphenoxy)-2-hydroxy-3-amino-propans und deren Saeureadditionssalzen
US3577432A (en) 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines
US4029801A (en) 1970-09-03 1977-06-14 John Wyeth & Brother Limited Pharmaceutical compositions and methods of treating hypertension
JPS5511670B1 (enExample) 1971-07-13 1980-03-26
US4080328A (en) * 1971-07-13 1978-03-21 Sumitomo Chemical Company, Limited N-substituted heterocyclic derivatives and preparation thereof
US3755584A (en) 1972-04-03 1973-08-28 Abbott Lab Tranquilizers
FR2190430A1 (en) 1972-06-29 1974-02-01 Ferlux N-aminomethylhydroxamic acids - with antiinflammatory activity pre-pared by Mannich reaction
US3894030A (en) 1973-01-04 1975-07-08 Janssen Pharmaceutica Nv 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3818017A (en) 1973-01-04 1974-06-18 Janssen Pharmaceutica Nv 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US4166119A (en) 1978-04-14 1979-08-28 American Hoechst Corporation Analgesic and tranquilizing spiro[dihydrobenzofuran]piperidines and pyrrolidines
WO1980000152A1 (fr) * 1978-07-03 1980-02-07 Sandoz Ag Derives d'un 3-aminopropoxy-aryle, leur preparation et utilisation
US4264613A (en) 1979-08-01 1981-04-28 Science Union Et Cie, Societe Francaise De Recherche Medicale Piperidylbenzimidazolinone compounds
FR2469411A1 (fr) 1979-11-15 1981-05-22 Science Union & Cie Nouveaux derives de la piperidylbenzimidazolinone, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
EP0095454A3 (de) 1982-05-13 1985-04-03 Gerot-Pharmazeutika Gesellschaft m.b.H. Neue kernsubstituierte Pyrogallol-Derivate
JPS59222484A (ja) 1983-06-02 1984-12-14 Kowa Co テトラヒドロナフチルカルボン酸フエニルエステル誘導体
US5614533A (en) 1987-03-13 1997-03-25 Bio-Mega/Boehringer Ingelheim Research, Inc. Substituted pipecolinic acid derivatives as HIV protease inhibitors
DE3723568C2 (de) 1987-07-16 1994-01-27 Siemens Ag Differenzstromschutzschalter
DE3723648A1 (de) 1987-07-17 1989-01-26 Sandoz Ag Indol-derivate, ihre herstellung und sie enthaltende arzneimittel
ES2027897A6 (es) 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina.
IL105716A0 (en) 1992-06-08 1993-09-22 Richter Gedeon Vegyeszet Aminopropanol derivatives,their preparation and pharmaceutical compositions containing them
FI933472A7 (fi) 1992-08-07 1994-02-08 Sankyo Co Peptider med foermaoga att inhibera effekten av HIV-proteas, deras framstaellning och terapeutiska anvaendning
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5576321A (en) 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5614523A (en) 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5627196A (en) 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
DE19703131A1 (de) 1997-01-29 1998-07-30 Bayer Ag Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
AU744685B2 (en) 1997-11-18 2002-02-28 Teijin Pharma Limited Cyclic amine derivatives and their use as drugs
DE19755268A1 (de) 1997-12-12 1999-06-17 Merck Patent Gmbh Benzamidinderivate
FR2780057B1 (fr) 1998-06-18 2002-09-13 Sanofi Sa Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2350730A1 (en) 1998-12-18 2000-06-22 George V. Delucca N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
WO2000035449A1 (en) 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2942000A (en) 1999-03-11 2000-09-28 Banyu Pharmaceutical Co., Ltd. Novel piperidine derivatives
CZ20013451A3 (cs) 1999-03-26 2002-04-17 Astrazeneca Ab Nové sloučeniny
US7125895B1 (en) 1999-05-14 2006-10-24 Bristol-Myers Squibb Pharma Research Labs, Inc. Cyclic amine derivatives and their uses
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
ATE356624T1 (de) * 1999-12-17 2007-04-15 Sanofi Aventis Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
FR2802533B1 (fr) * 1999-12-17 2002-02-15 Sanofi Synthelabo Phenoxypropanolamines, leur preparation et leur application en therapeutique
CO5300399A1 (es) * 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
GB0011838D0 (en) 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
BR0208336A (pt) 2004-03-23
EP1372651B1 (en) 2007-03-07
CN1538844A (zh) 2004-10-20
ZA200306792B (en) 2004-11-29
US20040122020A1 (en) 2004-06-24
EP1372651A1 (en) 2004-01-02
CA2441933A1 (en) 2002-10-03
DE60218641T2 (de) 2007-11-29
KR20030085030A (ko) 2003-11-01
ATE355842T1 (de) 2007-03-15
WO2002076457A1 (en) 2002-10-03
NO20034215D0 (no) 2003-09-22
US7345063B2 (en) 2008-03-18
PT1372651E (pt) 2007-05-31
MXPA03008443A (es) 2004-01-29
JP2004524345A (ja) 2004-08-12
IL157653A0 (en) 2004-03-28
ES2280511T3 (es) 2007-09-16
SI1372651T1 (sl) 2007-06-30
DE60218641D1 (de) 2007-04-19
DK1372651T3 (da) 2007-05-29
NO20034215L (no) 2003-11-24
NZ528296A (en) 2005-03-24

Similar Documents

Publication Publication Date Title
IS6658A (is) Ný efnasambönd
PT1263725E (pt) Novos compostos
SE0104140D0 (sv) Novel Compounds
SE0103836D0 (sv) Novel compounds
SE9904652D0 (sv) Novel Compounds
SE0200920D0 (sv) Novel compounds
SE0300480D0 (sv) Novel compounds
SE0302811D0 (sv) Novel compounds
ATE316083T1 (de) Adamantanderivate
SE0302139D0 (sv) Novel compounds
SE0202133D0 (sv) Novel compounds
SE9902987D0 (sv) Novel compounds
SE0104251D0 (sv) Novel compounds
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
SE0202539D0 (sv) Compounds
TW200604197A (en) New compounds
SE0101038D0 (sv) Novel compounds
SE9902765D0 (sv) Novel compounds
GB0104050D0 (en) Chemical compounds
SE0102716D0 (sv) Novel compounds
GB0120461D0 (en) Novel compounds
SE0303280D0 (sv) Novel compounds
SE0003476D0 (sv) Compounds
SE9902551D0 (sv) Novel compounds
DE60201074D1 (en) Pyrazolopyridinderivate